Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-4538HSC in Pediatric Patients With Malignant Solid Tumors and Epithelioid Sarcoma
NCT07734116Phase 2Recruiting
- Sponsor
- Ono Pharmaceutical
- Start
- Sep 2026
- Primary completion
- Nov 2029
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in malignant solid tumor, epithelioid sarcoma (ES), sponsored by Ono Pharmaceutical. Started Sep 2026; status: recruiting.
02
Drugs
03
Conditions
malignant solid tumorepithelioid sarcoma (ES)
Beyond the preview
Go deeper on NCT07734116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07734116.